This week addressed AI accountability, CPHI award winners, NFC anticounterfeiting, first-in-class FDA approvals, and a shelved FDA voucher pilot lead this week’s roundup.
|Articles|April 7, 2009
2009 Post-Interphex Showcase: Information Technology
2009 Post-Interphex Showcase: Information Technology
Advertisement
Website
Natoli has redesigned its website to provide clients with more information. The new website features quote-request forms for tooling and products. Advanced search capabilities allow users to easily search products or parts by name, manufacturer, part or item number, or product description.
Natoli Engineering Company, St. Charles, MO
tel. 636.926.8900
Webcast
Dow offers a webcast about hot melt extrusion. Mark Hall, lead development specialist within the company’s Pharmaceutical Excipients Research and Development Group, hosts the webcast titled “Impact of Polymeric Excipient Selection and Process Variables on Hot Melt Extrusion.” The webcast is available at Dow’s website under the “Pharmaceuticals” tab in the “Markets and Applications” menu.
Dow Wolff Cellulosics, Midland, MI
tel. 800.447.4369
Advertisement
Related to this article
Cole and Jaenisch explain why defending against AI poisoning in pharma manufacturing calls for a data steward role, immutable instruction ledgers, and automation.
Gloveless isolators don’t end interventions. Learn to assess intervention dependency in robotic aseptic filling and when glove ports are justified.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how the company’s product is worth the investment by protecting products and patients.
The FDA has shelved its National Priority Voucher pilot, leaving sponsors that built CMC and launch-readiness plans around 1- to 2-month reviews facing uncertain timelines.
Regulators will test pharma companies against their own internal AI policies. Jaenisch, Muraru, and Pandey explain how to build defensible, inspection-ready AI practices.
Terry Katz, CEO and co-founder of ForgeStop Technology Corporation, explains how its connected technology can enhance anticounterfeiting and how data are handled within the product.
Celtic Renewables won the CPHI Award for Sustainable Pharma Excellence for its green chemicals used in pharmaceutical manufacturing. Bettina Brierley, chief commercial officer, talks about the adoption, capacity, and pricing of biosolvents.
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Signs Point to FDA Shelving Priority Voucher Pilot, Stalling Fast-Track Drug Reviews
2
France Remains One of Europe’s Leading Biotech Funding Hubs
3
CPHI Milan Future Leader Award Winner: Pauline van der Wijst-Janssen
4
The Impact of Excipients on Continuous Manufacturing and the Risk of Nitrites
5